Répertoire des subventions financées

Filtrer par

688 ésultat(s) trouvé(s)

Measuring and Improving the Quality of Community-Based Dementia Care

  • Type de subvention

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Advancing Research on Care and Outcome Measurement (ARCOM)

  • Province

    Alberta

  • Date de Début

    2024

  • Montant total du financement

    $226,900

  • Contribution Santé Canada

    $113,450

Aperçu du projet

There are an increasing number of people living with dementia. Improving and maintaining quality of life is rated as the highest priority for people living with dementia and their caregivers. While many factors contribute to quality of life, high quality health care is an important component of optimizing quality of…

Apolipoprotein receptor 2 in AD-related brain vessel dysfunction

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer’s Association International Grant Program

  • Province

    Alberta

  • Date de Début

    2024

  • Montant total du financement

    $199,300

  • Contribution Santé Canada

    $81,500

Aperçu du projet

What is the role of apolipoprotein receptor 2, a protein found in the brain vessels, in Alzheimer's disease ? The brain vascular system is critical to supply the necessary energy and control the transport of molecules in and out of the brain. Failure of this system is seen early in…

Examining vascular risk and menopausal age on women’s increased risk for AD

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer’s Association International Grant Program

  • Province

    Ontario

  • Date de Début

    2023

  • Montant total du financement

    $199,540

  • Contribution Santé Canada

    $90,700

Aperçu du projet

Two-thirds of individuals suffering from Alzheimer’s disease are women. The reason for women’s increased risk of Alzheimer's disease is unknown. Menopause occurs when a decline in a hormone called estrogen causes middle-aged women to stop having menstrual periods. Early menopause can increase the risk of Alzheimer's disease. Vascular conditions, such…

Targeting KCC2 for rescuing functional impairments in Alzheimer’s disease

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer’s Association International Grant Program

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $200,000

  • Contribution Santé Canada

    $100,000

Aperçu du projet

Background Within the brain, cells communicate by sending signals that either enhance or dampen the activity of other cells. Balancing these excitatory and inhibitory signals is vital for the brain to function. Many components maintain this balance, but one key player is the protein KCC2. As levels of KCC2 are…

Self-disclosure about dementia on social media: evidence-informed guidance

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer’s Association International Grant Program

  • Province

    British Columbia

  • Date de Début

    2023

  • Montant total du financement

    $149,666

  • Contribution Santé Canada

    $68,031

Aperçu du projet

Individuals who engage on social media often disclose a personal dementia diagnosis or identify as a caregiver, yet little is known about the impact of that disclosure. The goal of this project is to address this gap and develop a resource to support users to navigate social media. We will…